A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
NCT: NCT05637801 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).
Frequently Asked Questions
What is A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)?
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) is a clinical trial registered under NCT05637801. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05637801?
The current status of NCT05637801 (A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)) is: ACTIVE_NOT_RECRUITING.
When did A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) start?
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) started on 2022-12-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.